Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -90.13% | -99.37% | -99.46% | -99.01% | 338.89% |
| Total Receivables | 171.43% | -80.22% | -65.31% | -98.46% | -78.79% |
| Inventory | -84.49% | -91.08% | -38.86% | -38.55% | -43.39% |
| Prepaid Expenses | -26.13% | -26.60% | 77.40% | -38.18% | -54.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -75.65% | -85.15% | -60.60% | -87.50% | -27.01% |
|
|
|||||
| Total Current Assets | -75.65% | -85.15% | -60.60% | -87.50% | -27.01% |
| Net Property, Plant & Equipment | -37.81% | -37.41% | -32.44% | -31.38% | -43.64% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -11.02% | -10.73% | -10.45% | -10.18% | -21.56% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -84.62% | -88.14% | -64.14% | -65.11% | 182.61% |
| Total Assets | -7.73% | -9.34% | -8.25% | -13.26% | -12.77% |
|
|
|||||
| Total Accounts Payable | 139.88% | 196.02% | 147.47% | 137.95% | 30.20% |
| Total Accrued Expenses | 46.37% | 207.23% | 23.08% | 9.77% | -37.58% |
| Short-term Debt | -23.20% | -16.23% | -9.78% | -10.33% | 115.93% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 2,623.14% | 159.24% | -- |
| Total Other Current Liabilities | -- | -- | 2,623.14% | 159.24% | -- |
| Total Current Liabilities | 7.07% | 19.21% | 12.57% | 5.60% | 71.73% |
|
|
|||||
| Total Current Liabilities | 7.07% | 19.21% | 12.57% | 5.60% | 71.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -23.20% | -16.23% | -9.78% | -10.33% | 115.93% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 4.88% | 12.74% | 8.09% | 3.54% | 40.45% |
|
|
|||||
| Common Stock & APIC | 26.63% | 27.44% | 29.91% | 29.91% | 6.32% |
| Retained Earnings | -29.42% | -35.49% | -36.66% | -38.91% | -28.61% |
| Treasury Stock & Other | -403.83% | -976.92% | -225.27% | -197.94% | -160.58% |
| Total Common Equity | -80.09% | -558.02% | -516.62% | -131.57% | -153.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.09% | -558.02% | -516.62% | -131.57% | -153.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.09% | -558.02% | -516.62% | -131.57% | -153.22% |
|
|
|||||